Skip to main content
Back to jobs

Senior Scientist, DMPK

External
atavistik-bio logoAtavistik-bio · Cambridge, MA
Full-timeOn-site1mo ago30+ days old, may be filled
Cover LetterConnect

Prepare for this interview

Elite

AI-generated questions, company research, and talking points tailored to this role

Requirements

  • PhD., Pharm. D. or equivalent training in pharmacokinetics, pharmaceutical sciences, or related disciplines.
  • 5+ years of experience in bio/pharmaceutical industry, combined with drug development.
  • Excellent communication and collaborative skills to work on multiple project teams including chemists, biologists and platform scientists.
  • Highly organized, self-motivated with a desire to succeed in a fast-paced organization.
  • Solid understanding of drug metabolism, bioanalysis, pharmacokinetics, preclinical pharmacology, and PK/PD modeling.
  • Expertise in SAR analysis and IVIVC.
  • Expertise managing CROs, GLP and other regulated activities.
  • Ability to operate objectively and independently as a leader and as a member of a team.
  • Experience with regulatory submissions for small molecules with a focus on preclinical is a plus.
  • Experience in nonclinical toxicology is a plus.

Benefits

Atavistik Bio offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance and a flexible spending account for either health care and/or dependent care.Candidate Privacy Notice:Atavistik Bio is an equal opportunity employer. All applicants will be considered for employment without regard to a person's race, color, religion, sex, sexual orientation, gender identity, national origin, veteran status, disability status, or any characteristic protected under applicable law.

Additional Information

Company Summary: Atavistik Bio is a privately-held clinical stage biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs. Our proprietary AMPS™ platform allows us to rapidly unlock functional cryptic pockets across a broad range of target classes to accelerate the development of groundbreaking medicines. We have rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, Regeneron Ventures, and RA Capital Management.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at atavistik-bio? Share your experience

Interested in this role?

Apply on the company's website.

Cover LetterConnect